$0.4123
-0.00775-1.85%
Ult. Agg.: Oct 26, 12:42 PM
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and...
È possibile acquistare azioni di AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. (OTCID:ATXI) attraverso qualsiasi broker online.
Non ci sono competitor di questo tipo per AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc..
AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. ha un obiettivo di prezzo condiviso di $56.25.
Il prezzo dell'azione per AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. (OTCID: ATXI) è di $0.41225 con l'ultimo aggiornamento 26 ottobre 2026 alle ore 12:42 GMT-4.
Non ci sono dividendi in programma per AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc..
Non sono previsti rapporti sui risultati per AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc..
Non c'è uno split imminente per AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc..
AVENUE THERAPEUTICS INC by Avenue Therapeutics, Inc. appartiene al settore Health Care e all'industria Pharmaceuticals. È quotata al OTCID.
Avenue Therapeutics Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. It is focused on advancing impactful therapies with the potential to...